105807-96-3

Basic information

• Product Name: 2H-1,4-Benzoxazin-3(4H)-one, 6-amino-4-[(4-chlorophenyl)methyl]-
• CAS NO: 105807-96-3
• Molecular Formula: C15H13ClN2O2
• Molecular Weight: 288.733
• Mol File: 105807-96-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2H-1,4-Benzoxazin-3(4H)-one, 6-amino-4-[(4-chlorophenyl)methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 2H-1,4-Benzoxazin-3(4H)-one, 6-amino-4-[(4-chlorophenyl)methyl]-(105807-96-3)
• EPA Substance Registry System: 2H-1,4-Benzoxazin-3(4H)-one, 6-amino-4-[(4-chlorophenyl)methyl]-(105807-96-3)

Safety Data

• Hazardous Substances Data: 105807-96-3(Hazardous Substances Data)

Upstream product

• 622-95-7 4-chlorobenzyl bromide 
• 35424-56-7 1-chloro-4-(iodomethyl)benzene 
• 81721-87-1 6-nitro-4H-benzo[1,4]oxazin-3-one 
• 105807-76-9 4-(4-chlorobenzyl)-6-nitro-2H-1,4-benzoxazine-3(4H)-one 

Downstream Products

• 1359817-89-2 4-(4-chlorobenzyl)-6-(3-trifluoromethylphenylamino)-2H-1,4-benzoxazine-3(4H)-one 
• 105808-35-3 4-(4-Chloro-benzyl)-6-isothiocyanato-4H-benzo[1,4]oxazin-3-one 

Relevant articles and documents

Heterocyclic Ring and Carbocyclic Derivative

The present invention provides novel compounds having a P2X3 and/or P2X2/3 receptor antagonistic effect, e.g. a compound of Formula (I): wherein R2 is a hydrogen atom or the like; ring A is five- to seven-cycloalkane or th

NOVEL HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

The present invention provides novel compounds having a P2X3 and/or P2X2/3 receptor antagonistic effect. A pharmaceutical composition having a P2X3 and/or P2X2/3 receptor antagonistic effect comprising a compoun